Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorHvidovre University Hospital
About this trial
This clinical study examines whether a co-designed mobility intervention can be delivered in routine hospital care after hip fracture surgery.
Hip fracture is a common and serious condition among older adults and is associated with loss of independence, complications, and increased mortality. During hospitalization, many patients remain inactive, even though early and frequent mobility is considered important for recovery.
The HIP-ME-UP intervention was developed in collaboration with healthcare professionals, patients, caregivers, and hospital management. It aims to support early mobilization, independence in basic mobility activities such as getting in and out of bed and increased physical activity during hospitalization.
The study will investigate whether the intervention is feasible to deliver in routine clinical practice, whether it is delivered as intended, and whether it is acceptable to patients and healthcare professionals.
Participants admitted after a hip fracture surgery will receive the intervention during hospitalization. Researchers will collect information on recruitment, retention, fidelity, acceptability, and mobility-related outcomes. Approximately 25 participants will be included.
The results will help determine whether a larger effectiveness study should be conducted.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 60 years.
Admitted to one of the two acute orthopedic wards at Copenhagen University Hospital Hvidovre (CUHH) following hip fracture surgery.
Pre-fracture Cumulated Ambulation Score (CAS) (by recall) ≥ 3 points, indicating independence or assisted independence in basic mobility activities such as bed transfer, chair transfer, and indoor walking.
Participants may be included if they are able to provide informed consent independently or if informed consent is obtained from a legally authorized proxy (e.g., caregiver or close relative) in cases of cognitive impairment. This applies to both Danish- and non-Danish speaking patients. Non-Danish speakers may be included with support from translated study materials and assistance from relatives or interpreters, where appropriate.
Disqualifiers
Non-ambulatory before the fracture, e.g. permanently bedbound or wheelchair-dependent.
Terminal illness with limited expected survival.
Post-operative weight-bearing restrictions precluding mobility activities.
Multiple fractures or suspected pathological fractures (e.g. related to malignancy).
Trial design
Design model
Single group
Treatments tested in this trial
HIP-ME-UP mobility intervention
BehavioralA multicomponent intervention designed to support early and frequent mobility during hospitalization after hip fracture surgery. The intervention includes a dedicated porter supporting mobility activities, standardized training concept to promote independence in bed transfer, group-based exercise supervised by physiotherapists, and encouragement of personal activities of daily living in the bathroom. The intervention is delivered by physiotherapists, occupational therapists, and porters as part of routine clinical care during hospitalization.
Treatment groups
25 Participants
are divided into 1 treatment groupGroup A: HIP-ME-UP mobility interventionExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Recruitment rate
Proportion of patients providing informed consent among those assessed for eligibility
Time frame
Continuous during recruitment period (up to 8 weeks)2
Retention rate
Proportion of included participants completing planned assessments
Time frame
At discharge and 4 months post-discharge3
Data completeness
Proportion of completed data among expected assessments
Time frame
Through study completion, up to 4 months post-discharge4
Fidelity of intervention delivery
Assessed via structured observations and logs reported as proportions and descriptive measures of adherence, dose, frequency, and quality
Time frame
Continuously targeted observations during the 8-week intervention periodOther outcomes
1
Basic mobility independence
Assessed using the Cumulated Ambulation Score, range 0-6, higher scores indicate better mobility independence
Time frame
Daily from inclusion until discharge2
In-hospital mobility
Assessed using Acute Care Mobility Assessment measuring walking activity during the previous 24 hours across three mobility levels (room, ward corridor, outside ward). Higher scores indicate greater in-hospital mobility
Time frame
Postoperative day 2, 4 and 63
Pre-fracture mobility
Assessed using New Mobility Score, range 0-9, higher scores indicate better pre-fracture mobility
Time frame
At inclusion and 4 months post-discharge4
Pain intensity
Assessed using Verbal Rating Scale, range 0-4, higher scores indicate greater pain intensity. Pain will be assessed at rest and during activity
Time frame
On inclusion and on postoperative day 2, 4, and 6Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Hvidovre University Hospital
Lead sponsor
Copenhagen University Hospital, Hvidovre
Sponsor institution
Source ClinicalTrials.gov